全球有数百万人正在服用GLP-1类药物以减轻体重和治疗其他疾病。
Millions of people worldwide are taking GLP-1s to lose weight and treat other conditions.
但一些临床医生告诉CNN，他们发现通过远程医疗平台获取这类药物的厌食症患者数量急剧上升，而这些平台几乎缺乏监管——后果是灾难性的。
But some clinicians tell CNN they're seeing sharp rises in the number of patients with anorexia accessing the drugs via telehealth platforms with little oversight – and disastrous consequences.